블로그

Frances Oldham Kelsey: 전기, 업적과 영원한 유산

Frances Kathleen Oldham Kelsey (née Oldham; July 24, 1914 – August 7, 2015) was a Canadian-American pharmacologist and physician who had a 45-year career with the U.S. Food and Drug Administration (FDA). As a reviewer, she refused to authorize thalidomide for market because she had concerns about the lack of evidence regarding the drug's safety. Her concerns proved to be justified when it was shown that thalidomide caused serious birth defects. Kelsey's career intersected with the passage of laws strengthening FDA oversight of pharmaceuticals. Kelsey was the first woman to receive a PhD in pharmacology and the second woman to receive the President's Award for Distinguished Federal Civilian Service, awarded to her by John F. Kennedy in 1962.

주요 사실

유산과 영향

The influence of Frances Oldham Kelsey extends far beyond her own lifetime. She fundamentally shaped healthcare and human longevity, and her medical discoveries and treatments remain foundational to this day.

Though she passed away in 2015, her ideas continue to be studied, debated, and built upon by scholars and practitioners worldwide.

Frances Oldham Kelsey은(는) Canada이(가) 배출한 가장 칭송받는 인재 중 한 명으로 남아 있으며, 그 지역의 풍부한 지적 유산을 보여준다.

Canada의 저명한 천재들

Canada은(는) 많은 뛰어난 인재를 배출했다. Frances Oldham Kelsey와(과) 더불어:

Canada의 모든 천재 보기 →

Medicine 분야의 더 많은 뛰어난 인물 보기

탐색 Medicine Geniuses

더 보기

Frances Oldham Kelsey의 전체 프로필 보기

Frances Oldham Kelsey 프로필 보기 →

더 많은 천재 탐색

1,300+ articles · 1,300+ biographies · 한국어

모두 보기